CPRX

CATALYST PHARMACEUTICAL PARTNERS, INC. Financials

moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners Observes Rare Disease Day Today

[GlobeNewswire] – CORAL GABLES, Fla. — Catalyst Pharmaceutical Partners, Inc. , a specialty pharmaceutical company focused on developing safe and effective, approved medicines targeting orphan neuromuscular and neurological … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)

[at noodls] – CORAL GABLES, Fla., March 27, 2013 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners to Present at 25th Annual ROTH Conference

[at noodls] – CORAL GABLES, Fla., March 7, 2013 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Catalyst’s Chief Executive Officer, and Steven Miller, … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations

[at noodls] – CORAL GABLES, Fla., March 5, 2013 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners Launches New Website

[at noodls] – CORAL GABLES, Fla., Feb. 21, 2013 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement

[at noodls] – CORAL GABLES, Fla., Dec. 27, 2012 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it received a Nasdaq Staff Deficiency Letter, dated December 24, 2012, indicating … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboardSee who Catalyst is hiring next, click here to view […]

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II(b) Trial for Cocaine Addiction

[at noodls] – CORAL GABLES, Fla., Nov. 8, 2012 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use of … moreView todays social media effects on CPRXView the latest stocks trending across Twitter. Click to view dashboard […]